Ponatinix 15 Mg (Ponatinib) – 60 Tablets

Ponatinix 15 Mg (Ponatinib) is a targeted therapy specifically designed for the treatment of chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL) in patients who are resistant or intolerant to other tyrosine kinase inhibitors (TKIs). Containing Ponatinib, Ponatinix 15 mg is a potent third-generation TKI that effectively targets the BCR-ABL1 fusion protein, including mutations like T315I, which are often resistant to earlier-generation TKIs.

Ponatinix 15 mg is indicated for the treatment of:

• Chronic Myeloid Leukemia (CML): Ponatinix 15 is used in adult patients with chronic, accelerated, or blast-phase CML who are resistant or intolerant to at least two other TKIs, including those with the T315I mutation.
• Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL): Ponatinix 15 is also indicated for the treatment of adult patients with Ph+ ALL who are resistant or intolerant to prior TKI therapy, particularly in cases with the T315I mutation.

Product Feature:

You will have the ability to order easily and pay the best price if you use Unit Pharmacy Website for buying Ponatinix 15 Mg (Ponatinib) medicine.